Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus

Vaccine

Volumn 25, Issue 3, 2007, Pages 547-560

  Jiang, Yunbo ^a   Fang, Liurong ^a   Xiao, Shaobo ^a   Zhang, Hui ^a   Pan, Yongfei ^a   Luo, Rui ^a   Li, Bin ^a   Chen, Huanchun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Immunogenicity; Membrane associated proteins; Porcine reproductive and respiratory syndrome virus; Protective efficacy; Recombinant pseudorabies virus

Indexed keywords

ENVELOPE GLYCOPROTEIN 5; ENVELOPE GLYCOPROTEIN 5 M; ENVELOPE PROTEIN; M PROTEIN; MEMBRANE PROTEIN; MODIFIED ENVELOPE GLYCOPROTEIN 5; NEUTRALIZING ANTIBODY; VACCINE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERIVIRUS; ARTICLE; BODY TEMPERATURE DISORDER; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; LUNG INJURY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OROPHARYNX; PARANASAL SINUS; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PSEUDORABIES HERPETOVIRUS; SWINE; VACCINATION; VIREMIA; VIRUS INFECTION; VIRUS LOAD; VIRUS RECOMBINANT;

ANIMALS; BODY TEMPERATURE; CELL PROLIFERATION; FEMALE; HERPESVIRUS 1, SUID; LYMPHOCYTES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PLASMIDS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; PSEUDORABIES; PSEUDORABIES VACCINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SWINE; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; VIREMIA; VIRUS SHEDDING;

EID: 33845192243     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.07.032     Document Type: Article

References (46)

1. Keffaber K.K. Reproductive failure of unknown etiology. Am Assoc Swine Pract Newslett 1 (1989) 1-10
2. Wensvoort G., Terpstra J.M., Pol E.A., Laak M., Bloemraad E.P., Kluyver C., et al. Mystery swine disease in the Netherlands: the isolation of Lelystad virus. Vet Q 13 (1991) 121-130
3. Meng X.J. Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development. Vet Microbiol 74 (2000) 309-329
4. Meulenberg J.J. PRRSV, the Virus. Vet Res 31 (2000) 11-21
5. Murtaugh M.P., Xiao P.Z., and Zuckermann F. Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection. Viral Immunol 15 (2002) 533-547
6. Dea S., Gagnon C.A., Mardassi H., Pirzadeh B., and Rogan D. Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates. Arch Virol 145 (2000) 659-688
7. Meulenberg J.J., Hulst M.M., de Meijer E.J., Moonen P.L., den Besten A., de Kluyver E.P., et al. Lelystad virus belongs to a new virus family, comprising lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus. Arch Virol Suppl 9 (1994) 441-448
8. Meulenberg J.J., Petersen-den B.A., de Kluyver E.P., Moormann R.J., Schaaper W.M., and Wensvoort G. Characterization of proteins encoded by ORFs 2 to 7 of Lelystad virus. Virology 206 (1995) 155-163
9. Wu W.H., Fang Y., Farwell R., Bien M.S.B., Rowland R.R.R., Christopher-Hennings J., et al. A 10-kDa structural protein of porcine reproductive and respiratory syndrome virus encoded by ORF2b. Virology 287 (2001) 183-191
10. Mardassi H., Massie B., and Dea S. Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. Virology 221 (1996) 98-112
11. Madsen K.G., Hansen C.M., Madsen E.S., Strandbygaard B., Botner A., and Sorensen K.J. Sequence analysis of porcine reproductive and respiratory syndrome virus of the American type collected from Danish swine herds. Arch Virol 143 (1998) 199-206
12. Mengeling W.L., Lager K.M., and Vorwald A.C. Safety and efficacy of vaccination of pregnant gilts against porcine reproductive and respiratory syndrome. Am J Vet Res 60 (1999) 796-801
13. Nilubol D., Platt K.B., Halbur P.G., Torremorell M., and Harris D.L. The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs. Vet Microbiol 102 (2004) 11-18
14. Barfoed A.M., Blixenkrone-Møller M., Jensen M.H., Bøtner A., and Kamstrup S. DNA vaccination of pigs with open reading frame 1-7 of PRRS virus. Vaccine 22 (2004) 3628-3641
15. Bastos R.G., Dellagostin O.A., Barletta R.G., Doster A.R., Nelson E., Zuckermann F., et al. Immune responses of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 22 (2004) 467-474
16. Jiang Y.B., Xiao S.B., Fang L.R., Yu X.L., Song Y.F., Niu C.S., et al. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity. Vaccine 24 (2006) 2869-2879
17. Gagnon C.A., Lachapelle G., Langelier Y., Massie B., and Dea S. Adenoviral-expressed GP5 of porcine reproductive and respiratory syndrome virus differs in its cellular maturation from the authentic viral protein but maintains known biological functions. Arch Virol 148 (2003) 951-972
18. Kwang J., Zuckermann F., Ross G., Yang S., Osorio F., Liu W., et al. Antibody and cellular immune responses of swine following immunisation with plasmid DNA encoding the PRRS virus ORFs 4, 5, 6 and 7. Res Vet Sci 67 (1999) 199-201
19. Pirzadeh B., and Dea S. Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus. J Gen Virol 79 (1998) 989-999
20. Plana D.J., Climent I., Sarraseca J., Urniza A., Cortes E., Vela C., et al. Baculovirus expression of proteins of porcine reproductive and respiratory syndrome virus strain Olot/91. Involvement of ORF3 and ORF5 proteins in protection. Virus Genes 14 (1997) 19-29
21. Hooft van Iddekinge B.J., de Wind N., Wensvoort G., Kimman T.G., Giekens A.L., and Moormann R.J. Comparison of the protective efficacy of recombinant pseudorabies viruses against pseudorabies and classical swine fever in pigs; influence of different promoters on gene expression and on protection. Vaccine 14 (1996) 6-12
22. Osorio Y., and Ghiasi H. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge. J Virol 79 (2005) 3297-3308
23. Souza A.P., Haut L., Reyes-Sandoval A., and Pinto A.R. Recombinant viruses as vaccines against viral diseases. Braz J Med Biol Res 38 (2005) 509-522
24. Veits J., Lüschow D., Kindermann K., Werner O., Teifke J.P., Mettenleiter T.C., et al. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J Gen Virol 84 (2003) 3343-3352
25. Ju C.M., Fan H.Y., Tan Y.D., Liu Z.F., Xi X., Cao S.B., et al. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Vet Microbiol 109 (2005) 179-190
26. Lv J.Q., Chen H.C., Zhao J.L., Fang L.R., and He Q.G. The development of recombinant Pseudorabies virus expressing porcine parvovirus VP2 gene and the study on its biological characters. J Virol Sinic 20 (2004) 133-137
27. van Zijl M., Wensvoort G., de Kluyver E., Hulst M., van der Gulden H., Gielkens A., et al. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol 65 (1991) 2761-2765
28. - mutant strain and the study on its biological property. Acta Microbiol Sinic 42 (2002) 370-374
29. Fang L.R., Jiang Y.B., Xiao S.B., Niu C.S., Zhang H., and Chen H.C. Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus. Virus Genes 32 (2006) 5-11
30. Chen H.C., Fang L.R., He Q.G., Jin M.L., Suo X.F., and Wu M.Z. Study on the isolation and identification of the Ea strain of Pseudorabies virus. J Anim Vet Sci Sinic 29 (1998) 97-104
31. + expressing GP5 of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and the preliminary study on its biological characterization. J Virol Sinic 20 (2004) 250-254
32. Mettenleiter T.C., and Rauh I. A glycoprotein gX-beta-galactosidase fusion gene as insertional marker for rapid identification of pseudorabies virus mutants. J Virol Methods 30 (1990) 55-65
33. Xiao S.B., Chen H.C., Fang L.R., Niu C.S., Zhang H., Jiang Y.B., et al. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice. Vaccine 22 (2004) 345-351
34. Qiu D.X., Chen H.C., He Q.G., Wu B., and Cao S.B. Detection of porcine serum antibody to Pseudorabies virus by ELISA. J Vet Sci Sinic 22 (2002) 149-152
35. Bounous D.I., Campagnoli R.P., and Brown J. Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Dis 36 (1992) 1022-1027
36. Christopher-Hennings J., Nelson E.A., Nelson J.K., Hines R.J., Swenson S.L., Hill H.T., et al. Detection of porcine reproductive and respiratory syndrome virus in boar semen by PCR. J Clin Microbiol 33 (1995) 1730-1734
37. Lopez O.J., and Osorio F.A. Role of neutralizing antibodies in PRRSV protective immunity. Vet Immunol Immunopathol 102 (2004) 155-163
38. Yang L., Frey M.L., Yoon K.J., Zimmerman J.J., and Platt K.B. Categorization of North American porcine reproductive and respiratory syndrome viruses: epitopic profiles of the N, M, GP5 and GP3 proteins and susceptibility to neutralization. Arch Virol 145 (2000) 1599-1619
39. Qiu H.J., Tian Z.J., Tong G.Z., Zhou Y.J., Ni J.Q., Luo Y.Z., et al. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet Immunol Immunopathol 106 (2005) 309-319
40. Ostrowski M., Galeota J.A., Jar A.M., Platt K.B., Osorio F.A., and Lopez O.J. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J Virol 76 (2002) 4241-4250
41. Alexander J., Fikes J., Hoffman S., Franke E., Sacci J., Appella E., et al. The optimization of helper T lymphocyte (HTL) function in vaccine development. Immunol Res 18 (1998) 79-92
42. Balasuriya U.B., Heidne H.W., Davis N.L., Wagner H.M., Hullinger P.J., Hedges J.F., et al. Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses. Vaccine 20 (2002) 1609-1617
43. Balasuriya U.B., Heidner H.W., Hedges J.F., Williams J.C., Davis N.Y., Johnston R.E., et al. Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles. J Virol 74 (2000) 10623-10630
44. Osorio F.A., Galeota J.A., Nelson E., Brodersen B., Doster A., Wills R., et al. Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. Virology 302 (2002) 9-20
45. Plagemann P.G. Neutralizing antibody formation in swine infected with seven strains of porcine peproductive and respiratory syndrome virus as measured by Iindirect ELISA with peptides containing the GP5 neutralization epitope. Viral Immunol 19 (2006) 285-293
46. Nodelijk G. Porcine reproductive and respiratory syndrome (PRRS) with special reference to clinical aspects and diagnosis. A review. Vet Q 24 (2002) 95-100